Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 7, 2016; 22(29): 6690-6705
Published online Aug 7, 2016. doi: 10.3748/wjg.v22.i29.6690
Published online Aug 7, 2016. doi: 10.3748/wjg.v22.i29.6690
Table 4 Results of the recovery studies
| Compound | Labelled amount | Added amount | Found amount | Recovery | RSD |
| Cholesterol | 1.0 mg | 0.80 mg | 0.79 mg | 99.8% | 1.6% |
| 1.00 mg | 1.00 mg | 100.0% | 1.1% | ||
| 1.20 mg | 1.19 mg | 99.6% | 1.2% | ||
| Hypericin | 0.0025 μg | 0.0020 μg | 0.0029 μg | 108.8% | 0.4% |
| 0.0025 μg | 0.0026 μg | 101.7% | 0.1% | ||
| 0.0030 μg | 0.0032 μg | 103.6% | 1.6% |
- Citation: Miranda Cona M, Liu YW, Hubert A, Yin T, Feng YB, de Witte P, Waelkens E, Jiang YS, Zhang J, Mulier S, Xia Q, Huang G, Oyen R, Ni YC. Differential diagnosis of gallstones by using hypericin as a fluorescent optical imaging agent. World J Gastroenterol 2016; 22(29): 6690-6705
- URL: https://www.wjgnet.com/1007-9327/full/v22/i29/6690.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i29.6690